Monoclonal anti-IL-22 (Clone IL22JOP) blocking antibody and isotype control IgG2aκ (Clone eBR2a) were purchased from Thermo Fisher Scientific. Mice were administered anti-IL-22 (50 μg/mouse) or isotype intraperitoneally every 48 h until the conclusion of the experiment. For \recombinant IL-22 treatment, mice were injected with recombinant IL-22 (500 ng/mouse; PeproTech) intraperitoneally every 24 h until the conclusion of the experiment. Mice were administered these reagents at least five times before inducing PhZ-mediated anemia.
Monoclonal anti il 22 clone il22jop blocking antibody
Manufactured by Thermo Fisher Scientific
The Monoclonal anti-IL-22 (Clone IL22JOP) blocking antibody is a laboratory reagent designed to neutralize the activity of the interleukin-22 (IL-22) cytokine. This antibody is a tool used in research applications to study the biological functions of IL-22 in various experimental settings.
Automatically generated - may contain errors
Lab products found in correlation
2 protocols using monoclonal anti il 22 clone il22jop blocking antibody
1
Anti-IL-22 Antibody and Recombinant IL-22 in Anemia
2
Anti-IL-22 Antibody and Recombinant IL-22 in Anemia
Check if the same lab product or an alternative is used in the 5 most similar protocols
+ Expand
Monoclonal anti-IL-22 (Clone IL22JOP) blocking antibody and isotype control IgG2aκ (Clone eBR2a) were purchased from Thermo Fisher Scientific. Mice were administered anti-IL-22 (50 μg/mouse) or isotype intraperitoneally every 48 h until the conclusion of the experiment. For \recombinant IL-22 treatment, mice were injected with recombinant IL-22 (500 ng/mouse; PeproTech) intraperitoneally every 24 h until the conclusion of the experiment. Mice were administered these reagents at least five times before inducing PhZ-mediated anemia.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!